Loading…
NeOnc Technologies Holdings, Inc. is projected to rise to $3.67 by 2027, a +5% move from its current price of $3.49. NTHI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.35 | $3.49 | $3.64 | +0.09% |
| Aug 6 | $3.30 | $3.50 | $3.71 | +0.18% |
| Aug 7 | $3.26 | $3.50 | $3.76 | +0.27% |
| Aug 8 | $3.23 | $3.50 | $3.80 | +0.36% |
| Aug 9 | $3.20 | $3.51 | $3.84 | +0.46% |
| Aug 10 | $3.17 | $3.51 | $3.88 | +0.55% |
| Aug 11 | $3.15 | $3.51 | $3.92 | +0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.15 | $3.51 | $3.92 | +0.64% |
| Week 2 | $3.03 | $3.53 | $4.12 | +1.28% |
| Week 3 | $2.95 | $3.56 | $4.30 | +1.93% |
| Week 4 | $2.88 | $3.58 | $4.45 | +2.58% |
| Week 5 | $2.82 | $3.60 | $4.60 | +3.24% |
| Week 6 | $2.78 | $3.63 | $4.73 | +3.90% |
| Week 7 | $2.74 | $3.65 | $4.87 | +4.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NeOnc Technologies Holdings, Inc. (NTHI) is a clinical-stage biopharmaceutical company focused on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers.
The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
NeOnc Technologies Holdings operates in the biotechnology sector, focusing specifically on intracranial malignancies and related therapies, with its symbol and listing tracked for investors seeking exposure to early-stage neuro-oncology candidates.
NeOnc Technologies Holdings (NTHI) is currently trading at $3.67 with a market cap of $87.39M, and it ranks 5315 by market capitalization.
The stock’s near-term outlook is framed by a 30-day range of $2.65 to $5.09 and a technical backdrop that shows BEARISH sentiment (RSI(14) 40) with a SMA50 of $4.62 and a SMA200 of $7.51. Support sits at $3.25 and resistance at $5.27.
The year-by-year forecast provides a longer horizon view: 2026 data show min $3.25, avg $3.67, max $5.27 with ROI 0 and NEUTRAL sentiment, and 2027 min $2.79, avg $3.85, max $5.75 with ROI 5 and NEUTRAL sentiment. As the series extends into the late 2020s and beyond, the forecast grows increasingly bullish, with 2028 avg $4.77, 2029 avg $5.74, and 2030 avg $4.90, culminating in a 2050 avg of $12.45 and a max of $28.64 with a ROI of 239.3 and BULLISH sentiment.
A major floor 43.2% below — a decisive break under it would weaken the trend.
The nearest floor, 6.9% below — buyers have tended to step in here.
The nearest ceiling, 51.0% above — a clean break opens room to run.
A major ceiling 115.8% above — clearing it would confirm fresh momentum.
Key NTHI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NTHI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.48 | Buy | $3.49 | Sell |
| MA 10 | $3.48 | Buy | $3.55 | Sell |
| MA 20 | $3.77 | Sell | $3.75 | Sell |
| MA 50 | $4.35 | Sell | $4.33 | Sell |
| MA 100 | $5.23 | Sell | $5.25 | Sell |
| MA 200 | $7.22 | Sell | $6.43 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.05 | Neutral |
| Stoch RSI (14) | 85.99 | Sell |
| CCI (20) | -45.84 | Neutral |
| Williams %R (14) | -44.19 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -1.41 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 55.81 | Neutral |
| TRIX (15) | -1.05 | Sell |
| Awesome (5,34) | -0.68 | Sell |
| Ultimate (7,14,28) | 25.39 | Buy |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 3.48 | Buy |
| ADX (14) | 23.32 | Sell |
| ATR (14) | 0.13 | Info |
The 30-day technical picture points to BEARISH sentiment with RSI(14) at 40. The stock trades relative to the SMA50 at $4.62 and the SMA200 at $7.51. Near-term support is identified at $3.25, with resistance at $5.27.
Within the last 30 days, the price has traded in a range from $2.65 to $5.09, indicating a consolidation that could resolve toward either the nearby support or resistance levels depending on catalysts and investor sentiment.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.25 | $3.49 | $4.77 | 0% | Neutral | |
| $2.76 | $3.67 | $5.23 | +5% | Neutral | |
| $3.12 | $4.35 | $6.57 | +25% | Bullish | |
| $3.48 | $5.06 | $7.97 | +45% | Bullish | |
| $3.05 | $4.59 | $7.50 | +32% | Bullish | |
| $2.72 | $4.25 | $7.15 | +22% | Bullish | |
| $2.65 | $4.27 | $7.39 | +22% | Bullish | |
| $2.66 | $4.42 | $7.84 | +27% | Bullish | |
| $3.14 | $5.38 | $9.75 | +54% | Bullish | |
| $3.29 | $5.80 | $10.73 | +66% | Bullish | |
| $3.25 | $6.55 | $13.19 | +88% | Bullish | |
| $5.15 | $11.45 | $26.02 | +228% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.25 | $3.49 | $4.39 | +0.00% |
| September 2026 | $3.18 | $3.83 | $4.78 | +9.64% |
| October 2026 | $3.11 | $3.79 | $4.82 | -0.90% |
| November 2026 | $2.94 | $3.62 | $4.66 | -4.61% |
| December 2026 | $2.95 | $3.66 | $4.77 | +1.10% |
Click any year to see its month-by-month NTHI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NTHI price prediction for 2026 points to an average of $3.49 (low $3.25, high $4.77) — a potential gain of 0% on today's $3.49. Price action looks broadly range-bound.
In 2027, NTHI is projected to trade between $2.76 and $5.23, averaging $3.67 — a potential gain of +5% from today's $3.49. That is up +5% on the projected 2026 average. A consolidation phase looks the most probable path here.
NeOnc Technologies Holdings, Inc.'s 2028 outlook centres on $4.35, within a $3.12 to $6.57 range. That is up +19% on the projected 2027 average. That marks a +25% change versus current levels. Momentum favours further upside here.
By 2029, NTHI could reach as high as $7.97, with a base case around $5.06 and support toward $3.48 — roughly +45% from $3.49. Buyers look set to stay in control over this stretch.
Expect NTHI to range from $3.05 to $7.50 through 2030. The $4.59 average target implies a +32% move from current prices. That is -9% versus the projected 2029 average. Momentum favours further upside here.
The NTHI price prediction for 2031 points to an average of $4.25 (low $2.72, high $7.15) — a potential gain of +22% on today's $3.49. Buyers look set to stay in control over this stretch.
In 2032, NTHI is projected to trade between $2.65 and $7.39, averaging $4.27 — a potential gain of +22% from today's $3.49. That is up +1% on the projected 2031 average. Momentum favours further upside here.
NeOnc Technologies Holdings, Inc.'s 2033 outlook centres on $4.42, within a $2.66 to $7.84 range. That is up +4% on the projected 2032 average. That marks a +27% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NTHI could reach as high as $9.75, with a base case around $5.38 and support toward $3.14 — roughly +54% from $3.49. Momentum favours further upside here.
Expect NTHI to range from $3.29 to $10.73 through 2035. The $5.80 average target implies a +66% move from current prices. That is up +8% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The NTHI price prediction for 2040 points to an average of $6.55 (low $3.25, high $13.19) — a potential gain of +88% on today's $3.49. Momentum favours further upside here.
In 2050, NTHI is projected to trade between $5.15 and $26.02, averaging $11.45 — a potential gain of +228% from today's $3.49. That is up +75% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NTHI today (≈ 286.532951 NTHI) could be worth
$3,280.7
+$2,280.7 (+228%) by 2050 · US Dollar
Based on the average projected NTHI price of $11.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NTHIwould be worth at today's price.
$1,000 invested in NTHI on Jul 31, 2025 (≈ 204.081629 NTHI) would be worth
$712.24
-$287.76 (-28.8%) today · 0.71× · US Dollar
Based on a NTHI entry price of $4.9 vs. today's $3.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.43 | $1,017.49 | +1.7% |
| 1 month ago | $4.46 | $782.51 | -21.7% |
| 3 months ago | $4.06 | $859.61 | -14.0% |
| 6 months ago | $9.27 | $376.48 | -62.4% |
| 1 year ago | $4.9 | $712.24 | -28.8% |
| All time (1.3y) ago | $12.11 | $288.19 | -71.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NTHI forecast.
Our base-case forecast reaches $7.00 around 2050.
Implied market cap at $7.00: $181.52M
The multi-year forecast paints a path of gradual upside, punctuated by periods of higher volatility. In 2026 the min/avg/max are $3.25/$3.67/$5.27 with ROI 0 and NEUTRAL sentiment, followed by 2027 with $2.79/$3.85/$5.75 and ROI 5 with NEUTRAL sentiment.
The trajectory strengthens thereafter: 2028 min $3.25, avg $4.77, max $7.59 with ROI 30 and a BULLISH sentiment; 2029 min $3.71, avg $5.74, max $9.60 with ROI 56.4 and BULLISH sentiment; 2030 min $3.01, avg $4.90, max $8.53 with ROI 33.4 and BULLISH sentiment.
Continuing years show continued bullish momentum: 2031 min $2.63, avg $4.48, max $8.08 (ROI 22), 2032 min $2.63, avg $4.67, max $8.69 (ROI 27.2), 2033 min $2.48, avg $4.59, max $8.79 (ROI 25.1), 2034 min $3.04, avg $5.86, max $11.50 (ROI 59.7), 2035 min $3.26, avg $6.52, max $13.10 (ROI 77.8).
The forecast then extends to 2040 with min $3.24, avg $7.20, max $15.90 (ROI 96.1) and to 2050 with min $5.60, avg $12.45, max $28.64 (ROI 239.3). Across these years, the sentiment remains BULLISH, signaling a pronounced upside potential despite the inherent volatility of early-stage biopharmaceutical equities. These figures are estimates and not guarantees, and actual results may differ due to a range of factors including clinical trial outcomes and market dynamics.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $4.90, a min of $3.01, and a max of $8.53, with a projected ROI of 33.4 and a BULLISH sentiment.
Forecasts show neutral sentiment in 2026 and 2027, then bullish sentiment from 2028 onward, with rising average values and ROI values such as 30 in 2028, 56.4 in 2029, 33.4 in 2030, 96.1 in 2040, and 239.3 in 2050.
Yes. The forecast shows a max price of $11.50 in 2034, $13.10 in 2035, $15.90 in 2040, and $28.64 in 2050, indicating the potential to exceed $10 in multiple years.
Current price is $3.67 and market cap is $87.39M.
The 30-day range is $2.65 to $5.09. RSI(14) is 40 with a BEARISH sentiment, SMA50 is $4.62 and SMA200 is $7.51. Support is $3.25 and resistance is $5.27.
NeOnc Technologies Holdings, Inc. Community Discussion
0Share your NeOnc Technologies Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.